Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer
- 1 January 2010
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 23 (1), 123-133
- https://doi.org/10.1038/modpathol.2009.145
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Triple negative tumours: a critical reviewHistopathology, 2007
- Use of immunohistochemical markers can refine prognosis in triple negative breast cancerBMC Cancer, 2007
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer SubtypesClinical Cancer Research, 2007
- Demystifying basal-like breast carcinomasJournal of Clinical Pathology, 2006
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFRThe American Journal of Surgical Pathology, 2006
- Phenotypic evaluation of the basal-like subtype of invasive breast carcinomaLaboratory Investigation, 2005
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences of the United States of America, 2003
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001